Moderna Inc. buy UBS Group AG
Start price
21.11.25
/
50%
€20.58
Target price
21.11.26
-
Performance (%)
15.57%
Price
22:26
€23.79
Summary
This prediction is currently active. The prediction currently has a performance of 15.57%. This prediction currently runs until 21.11.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Moderna Inc. | 1.342% |
| iShares Core DAX® | 0.396% |
| iShares Nasdaq 100 | 0.881% |
| iShares Nikkei 225® | 1.405% |
| iShares S&P 500 | 0.259% |
Comments by UBS_Group_AG for this prediction
In the thread Moderna Inc. diskutieren
Moderna (NASDAQ:MRNA) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Ratings data for MRNA provided by MarketBeat